Boulware et al. Affirms HCQ Efficacy, but Misinterpreted

fake news media, healthcare,

July 18 update. This study (NCT04308668, 03/17 – 05/20) has a second part, which was mis-reported on July 16 as Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 in the Annals of Internal Medicine. At the closer look, the study started on March 11 as a bona fide clinical trial, which devolved into a scientific fraud on or after March 24.  Read about it above: anti-HCQ Scientific Fraud, BS-2.

The first author, Dr. David Boulware, falsely denied that he was hired by  Revive Therapeutics Ltd., a psychedelic mushrooms peddler, as Scientific Advisor to promote its “orphan drug” Bucillamine (unrelated to psychedelic mushrooms), as a competitor to HCQ for COVID-19 .
Continue reading Boulware et al. Affirms HCQ Efficacy, but Misinterpreted →

Preparations to Pandemic Flu, 2006

healthcare,

Inglesby et al., Disease Mitigation Measures in the Control of Pandemic Influenza; Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science; 2006

It has been recognized that most actions taken to counter pandemic influenza will have to be undertaken by local governments, given that the epidemic response capacity of the federal government is limited. Continue reading Preparations to Pandemic Flu, 2006 →

Re HCQ Shortages

anti-social media, fake news media, google, healthcare, L2, ,

A new article in JAMA Network (Vaduganathan et al.) describes a peak in hydroxycholoroquine dispensing by pharmacies in the week of March 15-21, although misinterprets its cause. But its statistics confirms conclusions of my article Distributed Denial of HCQ to COVID-19 Victims, published in WUWT on May 11. That was panic buying by chronic lupus and/or rheumatoid arthritis patients, triggered by the news media and amplified by Google and so-called social media. On March 20, multiple outlets announced  that HCQ buying by COVID-19 patients was causing shortages for its “legitimate users”. There were no shortages at that time. But multiple repetitions of that lie caused lupus and RA patients to buy as much HCQ as they could – and many had unfulfilled prescriptions for 90 days.That led to actual shortages in a few days. Continue reading Re HCQ Shortages →

Anti-HCQ Paper in The Lancet Uses Fake Data

#Surgisphere, healthcare,

Good news: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis, Harvey A Risch, May 27, 2020,  American Journal of Epidemiology

Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy. Hydroxychloroquine+azithromycin has been used as standard-of-care in more than 300,000 older adults with multicomorbidities, with estimated proportion diagnosed with cardiac arrhythmias attributable to the medications 47/100,000 users … These medications need to be widely available and promoted immediately for physicians to prescribe.

Continue reading Anti-HCQ Paper in The Lancet Uses Fake Data →

Backup of Article under Attack for Advocacy against Lockdowns

Big Tech, healthcare, ,

The article We misunderstood coronavirus, now we underestimate its consequences is back on SJVSun, so this backup became unnecessary and has been removed. The original article was attacked immediately after its publication, on May 8-10, 2020.

The article discussed the response to the COVID-19 epidemic, and advocated for lifting lockdowns. At least one other article, co-authored by its author, was removed from Medium[.]com for this advocacy. This new article was available in its source only intermittently, probably because of a denial of service attack, involving Google, Facebook, and/or Microsoft employees and/or contractors.

Updated on 2020-12-17